Conversion to JCV Positivity Common With Natalizumab in MS Conversion to JCV Positivity Common With Natalizumab in MS

A study including longitudinal analysis of patients with MS treated with natalizumab shows no link between duration of treatment and conversion to JCV antibody positivity or PML. Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news